Example 10

Oncomice®, obtained through an in-house breeding program, were anesthetized intramuscularly with 0.1 mL of ketamine/acepromazine (1.8 mL saline, 1.0 mL ketamine, and 0.2 mL acepromazine) prior to dosing and tissue sampling. Individual mice were then injected via the tail vein with an imaging agent of the present invention (0.5-2.0 mCi/kg in 0.1 mL). Mice were euthanized and biodistribution performed at 1 h post-injection. Selected tissues were removed, weighed, and counted on a gamma counter. Results are expressed as the percentage of injected dose per gram tissue (mean±SEM; Table 3).

TABLE 3
Summary of imaging agent distribution in the Oncomouse ®
Imaging Agent Distribution
(% ID/g)
tissue246
blood1.07 ± 0.0600.41 ± 0.0990.88 ± 0.061
heart0.95 ± 0.0650.36 ± 0.0640.69 ± 0.073
lung0.97 ± 0.1210.45 ± 0.0711.69 ± 0.382
liver13.1 ± 2.1723.6 ± 5.1911.3 ± 1.73
spleen0.69 ± 0.0850.34 ± 0.0570.81 ± 0.021
kidney20.6 ± 3.2514.8 ± 1.796.66 ± 1.46
bone2.02 ± 0.3201.28 ± 0.2002.86 ± 0.124
muscle0.50 ± 0.0730.17 ± 0.0430.44 ± 0.049
urine71.87.67 ± 5.007.21 ± 6.71
tumor0.95 ± 0.1031.12 ± 0.2040.73 ± 0.026

Free full text: Click here